000 | 01971 a2200541 4500 | ||
---|---|---|---|
005 | 20250516094808.0 | ||
264 | 0 | _c20130821 | |
008 | 201308s 0 0 eng d | ||
022 | _a1469-5111 | ||
024 | 7 |
_a10.1017/S1461145712000545 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDuncan, Wallace C | |
245 | 0 | 0 |
_aConcomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. _h[electronic resource] |
260 |
_bThe international journal of neuropsychopharmacology _cMar 2013 |
||
300 |
_a301-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aBrain Waves _xdrug effects |
650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xblood |
650 | 0 | 4 |
_aDepressive Disorder, Major _xblood |
650 | 0 | 4 | _aElectroencephalography |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKetamine _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPsychiatric Status Rating Scales |
650 | 0 | 4 |
_aRiluzole _xtherapeutic use |
650 | 0 | 4 | _aSingle-Blind Method |
650 | 0 | 4 |
_aSleep Stages _xdrug effects |
650 | 0 | 4 | _aStatistics as Topic |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aSarasso, Simone | |
700 | 1 | _aFerrarelli, Fabio | |
700 | 1 | _aSelter, Jessica | |
700 | 1 | _aRiedner, Brady A | |
700 | 1 | _aHejazi, Nadia S | |
700 | 1 | _aYuan, Peixiong | |
700 | 1 | _aBrutsche, Nancy | |
700 | 1 | _aManji, Husseini K | |
700 | 1 | _aTononi, Giulio | |
700 | 1 | _aZarate, Carlos A | |
773 | 0 |
_tThe international journal of neuropsychopharmacology _gvol. 16 _gno. 2 _gp. 301-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1017/S1461145712000545 _zAvailable from publisher's website |
999 |
_c21845876 _d21845876 |